|
시장보고서
상품코드
2107847
원내감염 대책 시장 : 제품·서비스별, 최종사용자별, 지역별Hospital Acquired Infection Control Market, By Product and Service, By End User, By Geography |
||||||
원내감염 대책 시장은 2026년에 81억 2,000만 달러 규모에 달할 것으로 추정되고 있으며, 2033년까지 134억 6,000만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 7.5%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 81억 2,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 7.50% | 2033년 시장 규모 예측 : | 134억 6,000만 달러 |
병원내 감염(HAI)은 의료 시설에서 치료 중 환자가 감염된 모든 감염증을 의미합니다. 그 유형에는 중심정맥카테터 관련 혈류 감염(CLABSI), 카테터 관련 요로 감염(CAUTI), 수술 부위 감염(SSI), 인공호흡기 관련 폐렴(VAP) 등이 포함됩니다. 병원내 감염은 여전히 큰 과제로 남아 있으며, 환자의 발병률 및 사망률 상승, 입원 기간 연장, 그리고 비용 증가로 이어지고 있습니다.
전 세계 병원내 감염 예방 시장은 소독제, 멸균 장치, 감염 감시 소프트웨어, 항균 코팅, 개인용 보호복 등의 제품 유형에 따라 세분화되어 있습니다. 병원내 감염 유병률 증가, 수술 건수 증가, 의료 인프라 확충, 항생제 내성 문제의 심각화, 그리고 전 세계 의료 감염 예방 지침의 강화로 인해 병원내 감염 방지 시장에 대한 수요가 증가하고 있습니다.
시장 역학
전 세계 병원내 감염 방지 시장은 병원내 감염 증가, 외과수술 건수 증가, 그리고 고령자 및 면역 결핍 환자 증가에 의해 견인되고 있습니다. WHO, CDC, ECDC 등의 기관이 발표하는 엄격한 감염 예방 대책 및 지침에 대한 중요성이 부각되고, 다제내성균(MDRO)의 위협이 커지며, 더 우수한 멸균·소독 제품에 대한 수요가 증가하는 것도 기타 요인으로 꼽힙니다.
그러나 시장에는 첨단 고비용 기술의 도입 확대, 개발도상국의 의료 예산 제약, 그리고 과거 감염 예방 대책의 부적절한 이동 등 몇 가지 제약 요인이 존재합니다. 그럼에도 불구하고 AI를 활용한 감염 감시 솔루션, UV-C 소독, 로봇을 이용한 멸균 기술, 항균 코팅과 같은 기술적 진보에 더해, 의료 인프라에 대한 막대한 투자, 그리고 개발도상국에서 감염 예방의 중요성에 대한 의식의 향상가 병원내 감염 대책 시장에 새로운 성장 기회를 가져다줄 것입니다.
본 조사의 주요 특징
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 해설하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 시장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하는 경쟁 전략에 관한 중요 인사이트도 제공합니다.
- 본 조사에서는 다음 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적 및 전략)를 바탕으로 전 세계 병원내 감염 관리 시장의 주요 기업 개요을 소개하고 있습니다.
- 이 보고서에서 얻을 수 있는 인사이트를 통해 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있게 됩니다.
- 본 '세계의 병원내 감염 방지 시장’ 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 병원내 감염 관리 시장 분석에 사용된 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 수행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 원내감염 대책 시장 : 제품·서비스별, 2021-2033년
제5장 세계의 원내감염 대책 시장 : 최종사용자별, 2021-2033년
제6장 세계의 원내감염 대책 시장 : 지역별, 2021-2033년
제7장 경쟁 구도
제8장 애널리스트의 제안
제9장 참고 문헌 및 조사 방법
KSA 26.08.12Hospital Acquired Infection Control Market is estimated to be valued at USD 8.12 Bn in 2026 and is expected to reach USD 13.46 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 8.12 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.50% | 2033 Value Projection: | USD 13.46 Bn |
Hospital-acquired infections (HAIs), also called nosocomial infections, is defined as any infection acquired by a patient during medical treatment in a health-care setting. Types include central line-associated bloodstream infections (CLABSI), catheter-associated urinary tract infections (CAUTI), surgical site infections (SSI) and ventilator-associated pneumonia (VAP). Hospital-acquired infections still present major challenges, leading to higher patient morbidity and mortality, length of stay, and costs.
The global hospital acquired infection control market is segmented by the type of product and solution such as disinfectants, sterilization devices, infection surveillance software, and antimicrobial coating and personal protective clothing. The demand for hospital-acquired infection control market has increased because of growing prevalence of hospital acquired infections, increasing surgical operations, extending healthcare infrastructure, mounting problem of antimicrobial resistance and strict healthcare infection prevention guidelines globally.
Market Dynamics
The global hospital acquired infection control market is driven by increasing prevalence of hospital-acquired infections, the growing number of surgical procedures, and the rising number of elderly and immunocompromised patients. Increasing emphasis on rigorous infection prevention practices and guideline issued by organizations like WHO, CDC and ECDC, the rising threat of multidrug-resistant organisms (MDROs) and increasing demand for improved sterilization and disinfection products are other contributing factors.
However, a number of constraints are present in the market, such as increasing adoption of advanced and high-cost technologies, restricted healthcare budgets in underdeveloped countries, and improper implementation of infection prevention practices in the past. Nevertheless, advancements such as AI-enabled infection surveillance solutions, UV-C disinfection, robotic sterilization technologies, antimicrobial coatings, and considerable healthcare infrastructure investment along with expanding awareness of the significance of infection prevention in developing economies will offer new opportunities for growth in hospital acquired infection control market.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global hospital acquired infection control market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include STERIS plc, Getinge AB, Becton, Dickinson and Company, Ecolab Inc., 3M Company, Advanced Sterilization Products (ASP), bioMerieux SA, Belimed AG, Sotera Health Company, and Olympus Corporation
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global hospital acquired infection control market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hospital acquired infection control market
Market Segmentation
- Services Insights (Revenue, USD Bn, 2021 - 2033)
- Recruitment Services
- Managed Services
- Homecare Services
- Specialist Care Services
- Industry Verticals Insights (Revenue, USD Bn, 2021 - 2033)
- Pharmaceutical and Biotechnology
- Medical Devices
- Nursing/Healthcare
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- STERIS plc
- Getinge AB
- Becton, Dickinson and Company
- Ecolab Inc.
- 3M Company
- Advanced Sterilization Products (ASP)
- bioMerieux SA
- Belimed AG
- Sotera Health Company
- Olympus Corporation
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Hospital Acquired Infection Control Market, By Product and Service
- Global Hospital Acquired Infection Control Market, By End User
- Global Hospital Acquired Infection Control Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Industry Trends
4. Global Hospital Acquired Infection Control Market, By Product and Service, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Equipment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Hospital Acquired Infection Control Market, By End User, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals and ICUs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Long-term Care Facilities
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Hospital Acquired Infection Control Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product and Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product and Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product and Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product and Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product and Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product and Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
7. Competitive Landscape
- Company Profile
- STERIS plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Getinge AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ecolab Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- 3M Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Advanced Sterilization Products (ASP)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- bioMerieux SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Belimed AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sotera Health Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Olympus Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- STERIS plc
8. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
9. References and Research Methodology
- References
- Research Methodology
- About us
